Open AccessA Global Review of Hepatocellular Carcinoma (HCC)
Author(s) -
Gokul,
Premkumar Natarajan,
Joseph Vijay,
Janani Arul,
P Mumthaj.
Publication year - 2021
Publication title -
international journal of pharmaceutical sciences review and research
Language(s) - English
Resource type - Journals
ISSN - 0976-044X
DOI - 10.47583/ijpsrr.2021.v68i01.028
Subject(s) - hepatocellular carcinoma , sorafenib , medicine , cirrhosis , cancer , liver cancer , carcinoma , cause of death , causes of cancer , oncology , disease
Hepatocellular carcinoma is the leading cause of death in cirrhosis. Hepatocellular carcinoma is the sixth most prevalent cancer andthe third most frequent cause of cancer-related death. To review the risk factors, causes, morphology, enzymatic pathways andmanagement strategies involved in hepatocellular carcinoma. A literature search was performed using PubMed for publications with a predetermined search string to identify relevant studies. The diagnosis and treatment schedule used for the successful management of hepatocellular carcinoma. Studies combining sorafenib with locoregional or other targeted molecular therapies are likely to improve responses and outcome.